Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.
about
Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genesHuman Metapneumovirus: lessons learned over the first decadeNeutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion functionAntiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitroRespiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.Efficient generation of respiratory syncytial virus (RSV)-neutralizing human MoAbs via human peripheral blood lymphocyte (hu-PBL)-SCID mice and scFv phage display libraries.Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion proteinVaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus.HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion proteinPriming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challengeIdentification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles.A single amino acid change in the Newcastle disease virus fusion protein alters the requirement for HN protein in fusionChimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccineAntigenic relationships among human rotaviruses as determined by outer capsid protein VP4.CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment.Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein geneMolecular epidemiology and evolution of human respiratory syncytial virus and human metapneumovirus.Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease.Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidatesA wild goose metapneumovirus containing a large attachment glycoprotein is avirulent but immunoprotective in domestic turkeysVaccinia virus vectors: new strategies for producing recombinant vaccines.New insights for development of a safe and protective RSV vaccineProductive infection of isolated human alveolar macrophages by respiratory syncytial virusNucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses.The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanismAdditive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteinsModification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primates.A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles.Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease.Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV diseaseHost proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these yearsInducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells.An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice.Carriers for the delivery of a vaccine against respiratory syncytial virus.Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.Respiratory syncytial virus entry inhibitors targeting the F protein.
P2860
Q26782411-42A13B45-E9E5-4C77-87D7-42C1E03C199BQ26822938-3D2BE590-E17D-416E-8229-C98738E41482Q27486621-4C6A2FCB-DC5D-40E8-B9BF-9A86A7BFA30BQ28360752-2C25708F-8632-4FAE-B248-6C691F4F4ECFQ30240274-3D0BE6B8-EAAC-47F0-9140-8F480AD5C115Q30933288-4B8C73CD-8D00-4105-93D0-0200DF632C28Q33554501-173DCBF7-9397-49A8-828A-30344EE679B0Q33558356-2173E804-027B-4A07-89C2-E1F45EA99835Q33578748-93CB4E0E-AB28-4384-BB5F-5AD3D26765DFQ33603913-02DAC090-F510-430B-B1F2-5C1AC3F24BE2Q33783066-E38D8627-CFB2-4FC8-BF7C-8EE57B5FD6CDQ33785124-48DB0FC6-7D8F-499A-A011-C2CE799ED6E5Q33787073-DAD147B6-AA88-455D-A3F6-3FFE62202369Q33793103-7930F90D-239E-47C7-8A43-0C0758230424Q33795720-28180C83-3F82-404D-A2F4-188510BBB2D1Q33801890-31D9B9B2-7D86-4FA3-8D47-BD16380C0C6FQ33815412-AE8B5EF3-F8E0-4529-BDF6-8CA83879E9D2Q33829701-FC20D2C1-8B89-47B1-A40F-429686B7F7C7Q33842098-17C700F9-9409-412D-A6BE-45B08B6D510AQ33976286-438D9B53-FCB9-470D-B5CD-55203D9212CCQ33984333-B2A004EC-2D3A-4F54-BA74-66B10C395ACAQ34142727-391ABCA8-F06E-493A-ACCD-EAF1F0B59CFEQ34211635-EFC1B1D6-6611-4B26-83A8-F35AC26D2F66Q34249859-361596F2-6DDB-44CF-A776-9FDEE88CB99DQ34255436-873A95BD-C4D7-4D45-ADE2-241EB6981997Q34313909-509437BB-BF7B-4E50-8D8D-0E92F1B8F7B2Q34337480-33DB0394-230E-4C5B-AA40-0AB72E2F0AC8Q34492100-D39A0E7A-D4FC-4624-AC83-68BD78CE59E3Q34616642-DFE9A1A2-5DF3-4B6D-8046-7BF41EF3B080Q34651319-CC79D220-CDED-484A-A4FA-30FDDF54165CQ34948645-7DCDB9DE-5EF7-46F1-AE6F-A1FA38CB2E90Q34990420-51156E02-862C-423F-A532-53DED6EA0A37Q35070176-12168D4D-39D9-4DB4-BFF4-7E7C515287CCQ35488618-910C3B2D-39C7-45AF-BB5F-0F4826CF3704Q35566601-6943D083-2740-4EDA-A382-86C4D27D124AQ35856437-3A837339-C929-4DEE-986C-D58F90A720E6Q35893983-8017BF8F-C7C7-4EC1-8BAB-DD5E0BBA86A7Q36194078-6A45BBB8-8344-406E-989D-9A8AFD9C18CAQ36315159-2157A4F7-03BE-42E1-BA76-737D95AE6A5EQ36586879-54E4DF65-F5BA-4F94-BBAC-475DEA279E31
P2860
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of the F glycoprote ...... lycoproteins to host immunity.
@en
Expression of the F glycoprote ...... lycoproteins to host immunity.
@nl
type
label
Expression of the F glycoprote ...... lycoproteins to host immunity.
@en
Expression of the F glycoprote ...... lycoproteins to host immunity.
@nl
prefLabel
Expression of the F glycoprote ...... lycoproteins to host immunity.
@en
Expression of the F glycoprote ...... lycoproteins to host immunity.
@nl
P2093
P2860
P356
P1476
Expression of the F glycoprote ...... lycoproteins to host immunity.
@en
P2093
Chanock RM
Collins PL
Johnson PR
Olmsted RA
P2860
P304
P356
10.1073/PNAS.83.19.7462
P407
P577
1986-10-01T00:00:00Z